NMPA Approval

Valsartan and Amlodipine Tablets(I)

Approval Number

国药准字H20223856

Company天津市力生制药厂

Registration Date

November 15, 2022

Drug Information

Generic Name

缬沙坦氨氯地平片(Ⅰ)

Dosage Form

片剂

Strength

每片含缬沙坦80mg、氨氯地平5mg

Drug Type

化学药品

Registration Date

November 15, 2022

Company Information

Applicant Company

Company Name天津市力生制药厂

Company Address

天津市西青经济开发区赛达北一道16号

Manufacturing Company

Company Name天津市力生制药厂

Company Address

天津市西青经济开发区赛达北一道16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

缬沙坦氨氯地平片(Ⅰ) - NMPA 批准文号 | MedPath